Most of us are familiar with Alzheimer’s and realize the magnitude of such a dreadful disease. Individuals afflicted with this disease gradually lose cognitive functioning, usually starting with the loss of memory, and continuing on little-by-little through a loss of many different cognitive functions, eventually even losing control over bladder and bowels. The downward cycle of death can take several years. During this time, the families and caregivers experience tremendous suffering.
Now it’s possible that a “miracle enzyme” called Serrapeptase or Serratiopeptidase offers some excellent news for individuals who have Alzheimer’s and their families.
In a nutshell, Serrapeptase is a proteolytic enzyme. Proteolytic enzymes break the chainlike molecules of proteins into smaller fragments called peptides and eventually into amino acids. Proteolytic enzymes are found in plants but are more prevalent in animals. During digestion, in the stomach, protein first encounters the gastric enzyme pepsin. When it is passed to the small intestine, the undigested proteins are further digested by proteolytic enzymes secreted by the pancreas. That’s within the human body.
Other proteolytic enzymes include papain and bromelain, extracted from papaya and pineapple, respectively, and both available as supplements for people. And then there’s Serrapeptase, whose origin is bacteria in the silkworm moth digestive system, which the just-matured moth uses to dissolve the tough, fibrous cocoon and escape to the light of day. That cocoon is tough — and so is the silk which is made from the cocoon, so it needs something pretty effective at dissolving proteins, and Serrapeptase does the job.
Serrapeptase doesn’t just dissolve this precursor of silk, it can dissolve some different proteins in the human body, including amyloid plaque — the very material making up the infamous plaque tangles in the Alzheimer’s brain. Given that amyloid plaque may precede Alzheimer’s symptoms by a decade, Serrapeptase is an excellent addition to any Alzheimer’s prevention programs. For more information, visit http://www.Serrapeptase.org.